These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10737739)

  • 61. The Effect of Halogen-to-Hydrogen Bond Substitution on Human Aldose Reductase Inhibition.
    Fanfrlík J; Ruiz FX; Kadlčíková A; Řezáč J; Cousido-Siah A; Mitschler A; Haldar S; Lepšík M; Kolář MH; Majer P; Podjarny AD; Hobza P
    ACS Chem Biol; 2015 Jul; 10(7):1637-42. PubMed ID: 25919404
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis and structure-activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10.
    Endo S; Hu D; Suyama M; Matsunaga T; Sugimoto K; Matsuya Y; El-Kabbani O; Kuwata K; Hara A; Kitade Y; Toyooka N
    Bioorg Med Chem; 2013 Nov; 21(21):6378-84. PubMed ID: 24071447
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Virtual screening for inhibitors of human aldose reductase.
    Kraemer O; Hazemann I; Podjarny AD; Klebe G
    Proteins; 2004 Jun; 55(4):814-23. PubMed ID: 15146480
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular dynamics simulations of the structure of aldose reductase complexed with the inhibitor tolrestat.
    Rastelli G; Costantino L
    Bioorg Med Chem Lett; 1998 Mar; 8(6):641-6. PubMed ID: 9871575
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.
    Rittner HL; Hafner V; Klimiuk PA; Szweda LI; Goronzy JJ; Weyand CM
    J Clin Invest; 1999 Apr; 103(7):1007-13. PubMed ID: 10194473
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate.
    Harrison DH; Bohren KM; Ringe D; Petsko GA; Gabbay KH
    Biochemistry; 1994 Mar; 33(8):2011-20. PubMed ID: 8117658
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Structure of rat aldose reductase-like protein AKR1B14 holoenzyme: Probing the role of His269 in coenzyme binding by site-directed mutagenesis.
    Sundaram K; Dhagat U; Endo S; Chung R; Matsunaga T; Hara A; El-Kabbani O
    Bioorg Med Chem Lett; 2011 Jan; 21(2):801-4. PubMed ID: 21168333
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Kinetic and molecular docking studies of loganin and 7-O-galloyl-D-sedoheptulose from Corni Fructus as therapeutic agents for diabetic complications through inhibition of aldose reductase.
    Lee CM; Jung HA; Oh SH; Park CH; Tanaka T; Yokozawa T; Choi JS
    Arch Pharm Res; 2015 Jun; 38(6):1090-8. PubMed ID: 25315636
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expect the unexpected or caveat for drug designers: multiple structure determinations using aldose reductase crystals treated under varying soaking and co-crystallisation conditions.
    Steuber H; Zentgraf M; Gerlach C; Sotriffer CA; Heine A; Klebe G
    J Mol Biol; 2006 Oct; 363(1):174-87. PubMed ID: 16952371
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Potent and selective inhibition of the tumor marker AKR1B10 by bisdemethoxycurcumin: probing the active site of the enzyme with molecular modeling and site-directed mutagenesis.
    Matsunaga T; Endo S; Soda M; Zhao HT; El-Kabbani O; Tajima K; Hara A
    Biochem Biophys Res Commun; 2009 Nov; 389(1):128-32. PubMed ID: 19706287
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The structure of Apo R268A human aldose reductase: hinges and latches that control the kinetic mechanism.
    Bohren KM; Brownlee JM; Milne AC; Gabbay KH; Harrison DH
    Biochim Biophys Acta; 2005 May; 1748(2):201-12. PubMed ID: 15769597
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A.
    Howard EI; Sanishvili R; Cachau RE; Mitschler A; Chevrier B; Barth P; Lamour V; Van Zandt M; Sibley E; Bon C; Moras D; Schneider TR; Joachimiak A; Podjarny A
    Proteins; 2004 Jun; 55(4):792-804. PubMed ID: 15146478
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Discovery of new selective human aldose reductase inhibitors through virtual screening multiple binding pocket conformations.
    Wang L; Gu Q; Zheng X; Ye J; Liu Z; Li J; Hu X; Hagler A; Xu J
    J Chem Inf Model; 2013 Sep; 53(9):2409-22. PubMed ID: 23901876
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structure of a glutathione conjugate bound to the active site of aldose reductase.
    Singh R; White MA; Ramana KV; Petrash JM; Watowich SJ; Bhatnagar A; Srivastava SK
    Proteins; 2006 Jul; 64(1):101-10. PubMed ID: 16639747
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Zopolrestat as a human glyoxalase I inhibitor and its structural basis.
    Zhai J; Zhang H; Zhang L; Zhao Y; Chen S; Chen Y; Peng X; Li Q; Yuan M; Hu X
    ChemMedChem; 2013 Sep; 8(9):1462-4. PubMed ID: 23857942
    [No Abstract]   [Full Text] [Related]  

  • 76. Naphtho[1,2-d]isothiazole acetic acid derivatives as a novel class of selective aldose reductase inhibitors.
    Da Settimo F; Primofiore G; La Motta C; Sartini S; Taliani S; Simorini F; Marini AM; Lavecchia A; Novellino E; Boldrini E
    J Med Chem; 2005 Nov; 48(22):6897-907. PubMed ID: 16250648
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Binding of aldose reductase inhibitors: correlation of crystallographic and mass spectrometric studies.
    Rogniaux H; Van Dorsselaer A; Barth P; Biellmann JF; Barbanton J; van Zandt M; Chevrier B; Howard E; Mitschler A; Potier N; Urzhumtseva L; Moras D; Podjarny A
    J Am Soc Mass Spectrom; 1999 Jul; 10(7):635-47. PubMed ID: 10384727
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Modulation of aldose reductase inhibition by halogen bond tuning.
    Fanfrlík J; Kolář M; Kamlar M; Hurný D; Ruiz FX; Cousido-Siah A; Mitschler A; Rezáč J; Munusamy E; Lepšík M; Matějíček P; Veselý J; Podjarny A; Hobza P
    ACS Chem Biol; 2013 Nov; 8(11):2484-92. PubMed ID: 23988122
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Novel NADPH-binding domain revealed by the crystal structure of aldose reductase.
    Rondeau JM; Tête-Favier F; Podjarny A; Reymann JM; Barth P; Biellmann JF; Moras D
    Nature; 1992 Jan; 355(6359):469-72. PubMed ID: 1734286
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Potent, orally active aldose reductase inhibitors related to zopolrestat: surrogates for benzothiazole side chain.
    Mylari BL; Beyer TA; Scott PJ; Aldinger CE; Dee MF; Siegel TW; Zembrowski WJ
    J Med Chem; 1992 Feb; 35(3):457-65. PubMed ID: 1738141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.